SanBio Company Limited

4592・Growth Market・Pharmaceuticals

Official website

SanBio Company Limited

4592・Growth Market・Pharmaceuticals

Official website

SanBio Company Limited4592

Reference Indicators

Market Cap

811¥100M

P/E (Forecast)

—

P/B

6.1x

Dividend Yield (Forecast)

0.00%

ROE

-19.7%

EV/EBITDA

—

Financial Summary

Unit: ¥M

Item	2022Jan 2022	2023Jan 2023	2024Jan 2024	2025Jan 2025	2026Jan 2026
Operating Income	-6,620	-7,899	-4,539	-3,516	-3,794
Non-operating Income	2,095	3,334	1,752	627	6
Non-operating Expenses	54	134	37	133	503
Ordinary Income	-4,579	-4,698	-2,824	-3,022	-4,291
Extraordinary Income	29	1	285	11	—
Extraordinary Losses	10	0	3	—	—
Pre-tax Income	-4,560	-4,697	-2,542	-3,010	-4,291
Income Taxes	117	862	102	-127	-449
Net Income	-4,677	-5,559	-2,644	-2,882	-3,842
EBITDA	-6,488	-7,874	-4,525	-3,506	-3,786
ROA	-84.9%	-78.9%	-52.4%	-83.6%	-24.6%
ROE	-166.9%	-66.6%	-31.5%	-36.0%	-19.7%